Transcript Highlights:

• HB number forty-three by Ward Johnson relates to requiring a warning on the labeling of certain consumable
• 169 by Gonzalez of Dallas relating to the regulation of the cultivation, processing, packaging, labeling
• 169 by Gonzalez of Dallas relating to the regulation of the cultivation, processing, packaging, labeling
• , sale, testing, transportation, delivery, transfer, storage, dispensing, possession, and use of cannabis
• and cannabis products, and local regulation of cannabis establishments, authorizing the imposition of

Transcript Highlights:

• </c><00:13:48.639><c> industry</c> of the Hoy uh cannabis industry of the Hoy uh cannabis industry Association
• end quot and quot derived cannabis end quot and quot cannabis<00:30:00.760><c> end</c><00:30:01.000>
• </c> the EPA obviously in approving labels the EPA obviously in approving labels Fifer<01:15:06.040><
• ><c> not</c><01:15:08.120><c> something</c> Fifer labels and so that's not something Fifer labels and
• House Bill 918, House Draft 1, relating to labeling.

Committee: House Judiciary & Hawaiian Affairs

Summary: The committee first heard House Bill 302, which would repeal the requirement that a provider-patient relationship for medical cannabis certification be established in person first. The Department of Health said it supported the House Draft 2 version as a way to expand patient access, and several testifiers from the medical cannabis community and dispensary industry supported the bill, especially for patients on outer islands or those unable to travel. One witness asked that earlier language removed in committee be restored to further improve access. Representative Shimizu asked whether follow-up in-person visits would still occur, and DOH responded that this varies by provider, with some continuing in-person care and others moving to telehealth for chronic conditions. The committee then took up House Bill 712, relating to the federal 340B drug pricing program and contract pharmacies. The Office of Consumer Protection and the Attorney General’s office both said they supported the bill’s purpose but wanted it clarified and possibly moved into a standalone chapter rather than chapter 481B. Supporters, including Hawaii Pacific Health and the Queen’s Health Systems, said the bill is needed to protect safety-net funding and access to discounted drugs, citing large financial benefits from 340B and losses caused by manufacturer restrictions on contract pharmacies. PhRMA opposed the bill, arguing the issue is not access to discounts but accountability and transparency in how contract pharmacies distribute benefits, and said it was willing to discuss amendments. Members asked follow-up questions about whether there was data showing misuse; PhRMA said it did not have numbers, while hospital witnesses said the program is federally audited and used appropriately in Hawaii. Finally, the committee heard House Bill 1482, HD1, which would tighten hemp and controlled-substance definitions to exclude Schedule I cannabinoids from manufactured hemp products and clarify the treatment of artificially derived cannabis. The Department of Health supported the measure, saying it adds clarity to existing prohibitions. Kūre Hawaii and other supporters said it would close loopholes involving Delta-8 and similar products. An individual testifier urged stronger language to also cover compounds such as HHC, THCA, THCP, and THCO. In response to questions about enforcement against mislabeled hemp products, DOH explained that THC percentages are relative to product weight, that some products can remain under the hemp threshold while still containing significant THC, and that hemp flower is already prohibited from direct retail sale, though enforcement can be complicated and involves both administrative and criminal authorities.

Transcript Highlights:

• </c><00:38:50.960><c> program</c> that the therapeutic cannabis program that the therapeutic cannabis
• I represent Granite Leaf Cannabis.
• Granite Leaf Cannabis.
• It's all very clearly labeled. labeled. labeled.
• </c> plainly labeled. plainly labeled.

Committee: House Health, Human Services and Elderly Affairs

Transcript Highlights:

• Cannabis and cannabis, not just hemp.
• </c> SB 2421 relating to cannabis. SB 2421 relating to cannabis.
• Thank you very much. cannabis. It requires three triggers, cannabis.
• </c> of cannabis. Thank you very much. of cannabis. Thank you very much.
• <c> in</c><01:15:16.320><c> the</c> uh cannabis uh cannabis sellers in the uh cannabis uh cannabis sellers

Summary: The committee first heard SB 888, which would bar operators of smart household security devices from sharing user data with law enforcement unless the user consents or police obtain a warrant. DCCA’s Office of Consumer Protection offered comments and Judiciary submitted written support. Several individuals also submitted written support. The committee recommended passage with amendments clarifying that the Office of Consumer Protection may enforce violations and adopting Judiciary’s recommended changes, while also deferring the effective date to July 1, 2050. The motion passed unanimously among members present, with one senator excused. The committee then took up SB 2777 on insurance disclosures. The bill would require authorized insurers to disclose claim-handling data to consumers, including claims open at the start of a period, closed with payment, closed without payment, and open at the end of the period. The committee described amendments to clarify the bill, remove a requirement for the DCCA insurance division to handle publication, and defer the effective date to July 1, 2050. The measure was passed with amendments and the recommendation was adopted, with one member voting no and another excused. In a joint Commerce and Consumer Protection/Judiciary hearing on SP2738 relating to tax haven abuse, the Department of Taxation offered comments and the Tax Foundation testified in opposition, arguing the state should rely on IRS audits and existing worldwide reporting rules rather than create a separate state approach. Other written testimony was noted in both support and opposition. The committees recommended passage with amendments adopting Taxation’s technical changes and deferring the effective date to July 1, 2050; the recommendation was adopted, with one senator noting reservations. The joint hearing then moved to health-related bills, including SB 2690 on primary care spending, SB 3103 on energy assistance, SB 3137 on Department of Health authority over food, drugs, and cosmetics, SB 3164 on child welfare service organizations, and SB 3206 on cannabinoids. SB 2690 drew strong support from physicians and advocates who said it would address primary care shortages, especially on neighbor islands, while HMSA and others warned a fixed spending percentage could raise costs and suggested a working group. SB 3164 drew support from child welfare providers and opposition from the Attorney General over indemnification language, and SB 3206 drew mixed testimony: state agencies raised federal-law and vagueness concerns, while hemp and cannabis advocates and some farmers supported the measure and urged broader legalization or amendments.

Transcript Highlights:

• So, uh, from certifying for cannabis.
• We held a listening and labeling.
• I didn't do all these, but also cannabis use disorder, looking at cannabis in society.
• Well, the to certify me for cannabis.
• </c><01:17:52.320><c> use</c> and opioid use disorder and cannabis use and opioid use disorder and cannabis

Summary: The Health and Human Services Oversight Committee met on April 17 and approved the prior meeting minutes, then set its next meeting for May 29 at 9:30 a.m. Members also discussed a New Futures effort to collect questions about Medicaid changes and post answers as an FAQ, with a preference that the FAQ live on New Futures’ website rather than the state website. The commissioner’s office said it would coordinate responses and that the issue is still evolving. The main presentation was an HHS update focused on the state public health laboratory and its work during Public Health Lab Week. Officials reviewed the lab’s history, its biosafety functions, and its role in disease prevention, food safety, preparedness, and response. They highlighted mosquito surveillance for eastern equine encephalitis, West Nile virus, and Jamestown Canyon virus, noting that the lab tested more than a quarter million mosquitoes last year and that mosquito testing helps provide early warning for local public health decisions. They also discussed rabies testing, saying New Hampshire’s lab is the only one in the state that performs it, that rabies is fatal once symptoms begin, and that the work is preventable through early prophylaxis. Members asked about federal funding cuts, water testing, and whether CDC changes to rabies testing would affect New Hampshire. The department said it had been affected by an $80 million federal clawback but was managing through other funds and staff reassignments; for the water lab, temporary staff had been hired to continue swimming-area testing. Officials said the state remains able to handle rabies testing and that federal changes would mainly affect areas without similar services. They also answered questions on Jamestown Canyon virus, saying New Hampshire had one human case in 2025 and three in 2024, compared with zero West Nile cases in 2025 and one in 2024, and that weather and protective measures influence mosquito-borne disease levels. Additional questions covered biosafety levels, cyanobacteria coordination with the Department of Environmental Services, and the Brown Building flood mitigation, which was described as about halfway complete with a hoped-for reopening of the west side by June.

Transcript Highlights:

• The label says to agricultural use user.
• You know, sometimes there's misunderstanding about a federal label and a state label. And maybe Mr.
• Every pesticide label that is approved by the EPA is unique.
• Other products like Roundup have a caution label.
• Other products like Roundup have a caution label.

Bills: HF858 , HF2577 , HF2576

Committee: House Agriculture Finance and Policy

Keywords: bioincentive payments, agriculture, job creation, environmental compliance, financial reporting, waste handling, sewage sludge, PFAS regulation, environment, record retention, fertilizer disposal, pesticide disposal, environmental impact, safety regulations, burning prohibition

Transcript Highlights:

• </c><00:05:44.960><c> also</c> corrected that and the labeling also corrected that and the labeling also
• </c><00:56:31.040><c> in</c> federal law, we can look at cannabis in federal law, we can look at cannabis
• That product is then labeled not for sale.
• Basically, it’s going to be on the label.
• Basically, it’s going to be on the label.

Summary: The Environment and Agriculture Committee held a work session and then an executive session on HB 396, which would allow processing of beef cows, swine, sheep, and goats at facilities not certified by USDA. Representative Comtois presented a revised amendment after earlier drafting issues were corrected. She explained that the amendment now limits the amenable species language to cuts of meat rather than meat food products, fixes labeling language, removes an exemption from federal law, strikes a seasonal date range, and restores a section that had been removed. She also said the amendment distinguishes between amenable and non-amenable species and keeps a registration statement acknowledging the federal-law conflict. Committee members and witnesses debated the policy. Representative Howard questioned whether the bill should educate farmers rather than legislate them and raised concerns about requiring a farmer to register as violating federal law. Representative Comtois argued the bill supports small farmers, year-round meat processing, and intrastate activity, and described problems she said had occurred at USDA facilities. Representative Miner and others expressed support for moving the amendment forward. DHHS food safety officials testified that the department has no oversight of custom exempt facilities, that USDA is the only inspector in that system, and that if the bill passed there would be very limited regulatory oversight unless there were complaints or a foodborne outbreak. They also noted the original September 1 to April 30 date range had been tied to bison because of size and temperature concerns, and said the current language appeared to address bison, elk, and red deer documentation rather than the livestock species named in the bill. The New Hampshire Farm Bureau’s policy director, Rob Johnson, said the organization had recently voted down a policy opposing state regulations that would allow uninspected meat sales at retail until federal law changes, and that he needed to consult further with leadership before taking a position on HB 396. He suggested the bill should use the term “beef cattle” for consistency with livestock statutes. In executive session, Representative Comtois moved to approve amendment 2025-3090H, Representative King seconded, and members reiterated both support and reservations. The transcript ends during executive-session discussion, with no final recorded vote on the bill shown in the excerpt.

Transcript Highlights:

• those good actors who are sincere about addressing the science behind the medicinal application of cannabis
• The Native American community understands the medicinal application of marijuana and cannabis.

Bills: SJR50 , SJR51 , SJR52 , SJR53 , SJR54 , HJR1090 , HJR1091 , HJR1092 , HJR1093 , HJR1094 , HJR1095 , SJR49

Committee: Senate Administrative Rules

Keywords: Medicaid, federal funding, state law, healthcare, low-income adults, Oklahoma Constitution, healthcare regulations, Oklahoma Health Care Authority, permanent rules, joint resolution, OHCA, health care rules, administrative rules, major rule, Title 75, Title 317, Oklahoma Administrative Code, OAC 317:30, health policy, state health programs

Transcript Highlights:

• Why are cannabis and alcohol accepted, but psilocybin isn't?
• decriminalized possessing an ounce of cannabis with a $100 fine and confiscation.
• Why are cannabis and alcohol accepted, but psilocybin isn't?
• possessing an ounce of cannabis with a $100 fine and confiscation.
• When you take medication, you read the label. Like this label says, do not mix with the law.

Committee: Joint Joint Committee on the Judiciary

Summary: The committee opened with procedural guidance for a very large hearing, explaining testimony limits, written testimony procedures, and rules for maintaining order. Members then heard testimony on a wide range of bills, including proposals to define antisemitism using the IHRA definition, regulate facial recognition technology, restrict weaponized robotics and drone use, expand protections for journalists’ confidential sources, address access to decedents’ email accounts, and create or adjust rules around municipal enforcement and animal cruelty fines. Several sponsors and advocates asked for favorable reports, and committee members asked clarifying questions on implementation, costs, and how the bills would interact with existing law. On facial recognition, sponsors and advocates described the technology as a threat to privacy, due process, and civil liberties, and urged adoption of the Special Commission’s recommendations, including warrant requirements, notice to defendants, and limits on untargeted surveillance. Support came from legislators, the ACLU, CDT, EFF, and a UMass professor, while committee members asked about current state law and municipal bans. On robotics, Senator Moore and industry witnesses from MassRobotics, Boston Dynamics, and AUVSI supported a bill prohibiting weaponized robots and requiring warrants for certain law enforcement uses, describing it as a public-safety and trust-building measure. On the shield law bill, newspaper publishers, journalists, NEFAC, and the Reporters Committee argued Massachusetts needs statutory protection for confidential sources, citing costly subpoenas and chilling effects on reporting. The committee also heard testimony on a bill to expand the right of publicity to cover image and voice, with SAG-AFTRA members supporting protections against AI-driven exploitation and some discussion about viral content and consent. Another bill would allow limited access to a decedent’s email accounts, with one witness describing a family’s inability to use a deceased relative’s email to notify friends. The committee then took testimony on psilocybin-related bills: supporters described medical and personal benefits and argued for narrow decriminalization or study, while an opponent warned of public-health risks, impaired driving, and youth exposure; the Massachusetts Psychiatric Society supported limited, safety-based decriminalization. Finally, the committee heard strong support for a “safe reporting” bill for sex workers and trafficking survivors, with advocates saying immunity would encourage victims and witnesses to report crimes without fear of arrest, and members raised questions about how the immunity would work in practice.

Transcript Highlights:

• than either prior to cannabis cannabis than either prior to cannabis legalization<00:46:47.240><c> or
• Legalized cannabis is not unregulated cannabis, and legalized cannabis is not my grandparents' cannabis
• legalized</c> unregulated cannabis and legalized unregulated cannabis and legalized cannabis<01:02:11.720
• </c> cannabis is not my grandparents cannabis cannabis is not my grandparents cannabis actually<01:02
• c> to</c><02:09:21.480><c> help</c> cannabis cannabis credit co-ops to help cannabis cannabis credit

Summary: The House Committees on Judiciary and Hawaiian Affairs and Agriculture and Food Systems heard testimony and began decision-making on HB 1246, which would establish the Hawaii Cannabis and Hemp Office within DCCA to regulate cannabis. Chair Tarnas described the bill as divisive and noted the hearing had received 95 testimonies in support, 135 in opposition, and 11 comments. Members were told the office would be administratively attached to DCCA, and the department emphasized it would not direct day-to-day operations. DCCA also raised concerns about banking access due to federal law, while the Department of Agriculture supported a one-plant, one-agency approach and noted its current authority over cannabis plant importation and movement. Several agencies and advocates supported the bill with cautions or requested amendments. The Department of Health said it appreciated the bill’s public health protections but remained concerned about increased adult-use access, youth mental health, pregnancy-related risks, and effects on developing brains; it requested a 12-month delayed effective date. The Attorney General’s office said legalization should include safeguards, recommended a longer implementation timeline and seed funding, and flagged issues in the bill involving impaired driving, open-container language, and penalties for under-21 possession. The Office of the Public Defender supported the bill but objected to new driving and possession offenses, saying existing law already covers impaired driving. Doctors for Drug Policy Reform supported the measure, citing regulation of intoxicating cannabinoids, testing, childproof packaging, and public education as public-health benefits. Opponents focused on youth access, public safety, and the bill’s broader social effects. The Honolulu Police Department opposed the bill over access and diversion concerns, and the City and County of Honolulu Prosecutor strongly opposed legalization, citing higher-potency cannabis, youth harms, psychiatric risks, and increased poison-center calls. The Hawaiʻi Substance Abuse Coalition argued legalization should wait until prevention programs are in place and funded first, while the Hawaiʻi Family Forum and Hawaiian Republican Women also opposed the measure, citing concerns about youth exposure, added bureaucracy, and taxpayer costs. The Tax Foundation of Hawaiʻi questioned the purpose of the proposed cannabis taxes, asking why cannabis should be taxed heavily if legalization is intended. The hearing continued with additional testimony after a brief audio issue for one testifier.

Transcript Highlights:

• particular thing, this is what you would normally call, and we know in medicine is usually the term off-label
• And we know in medicine is usually the term off-label, and we do this with many other medications as
• The bill updates the statutory definition of low-THC cannabis by removing the dried flower specification
• so that it applies to all forms of cannabis, except edibles, and revises the CBD potency requirement
• with Senator Garcia regarding the Department of Health bill, but I am Melissa with the holistic cannabis

Bills: S0042 , S0196 , S0878 , S0902 , S0914 , S1092 , S1168 , S1340 , S1404 , S1414 , S1684 , S1686

Committee: Senate Appropriations Committee on Health and Human Services

Summary: The Appropriations Committee on Health and Human Services met to hear and vote on a series of health, human services, and education-related bills, along with a presentation of the committee’s proposed HHS budget. The budget was described as increasing by more than $2.1 billion over the current base, with major funding highlighted for Medicaid and KidCare, rural health, provider rate increases, child welfare, mental health and substance use, opioid treatment, Alzheimer’s initiatives, cancer research, ADAP, veterans’ services, and IT modernization. Public testimony on the budget focused heavily on AIDS Drug Assistance Program funding and concerns about Department of Health changes affecting access, premium assistance, notice, and continuity of care for people living with HIV/AIDS. Among the bills reported favorably were measures on podiatric medicine and tissue-based products (SB 1092), background screening and clearinghouse procedures (SB 1168), child protective investigations involving specific medical diagnoses and second opinions (SB 42), clinical laboratory personnel licensure standards (SB 878), uterine fibroid data tracking and research (SB 196), medical marijuana treatment center oversight and related health provisions (SB 902), dyslexia and dyscalculia screening and intervention in schools (SB 1340), memory care licensure for assisted living facilities (SB 1404), congenital CMV education materials (SB 1414), Parkinson’s disease registry and related public records exemption bills (SB 1684 and SB 1686), and occupational therapy dry needling licensure standards (SB 914). Several bills were amended before passage, including SB 1092, SB 42, SB 902, SB 1684, and SB 1404. Testimony generally came from professional associations, advocacy groups, and affected stakeholders, with support voiced for most measures. The committee adopted amendments on the floor, heard no opposition during debate on the bills described, and then voted to report each measure favorably. At the end of the meeting, senators requested to be recorded in the affirmative on selected bills, and the committee adjourned.

Transcript Highlights:

• The problem with the than cannabis.
• From um concerns about the labeling.
• She said labeling is a worthwhile adjustment that needs to be done to make sure labeling is accurate,
• </c><02:46:35.720><c> cannabis</c><02:46:36.200><c> sativa</c><02:46:37.320><c> is</c> that cannabis
• cannabis sativa is that cannabis cannabis sativa is uh uh uh both<02:46:40.200><c> hemp</c><02:46:40.600

Committee: House Environment and Agriculture

Transcript Highlights:

• We need to look at the Use of cannabis, but we need to have more discussion.
• So we're looking at something that has withdrawal symptoms similar to caffeine or cannabis.
• I'm not saying that this is... ...withdrawal symptoms similar to caffeine or cannabis.
• So to clarify, the label says you can only take one pill every two days, basically. Okay.
• The label says you can only take one pill every two days, basically. Okay.

Summary: The Senate Committee on Public Safety heard two bills. SB 99 by Senator Blakespear, sponsored by the U.S. Department of Defense, would improve coordination between civilian and military law enforcement in domestic violence cases involving military protective orders (MPOs). The bill would require courts to check for MPOs in the NCIC system when considering restraining orders, allow MPOs to be admissible evidence, require civilian officers to notify military law enforcement of possible MPO violations, and allow local agencies to enter MOUs with the military. Supporters said the bill would close jurisdictional gaps that can leave survivors unprotected; the ACLU opposed it unless amended, citing due process concerns because MPOs are issued by commanders without court process. The committee discussed amendments to make notification and MOU provisions less automatic and to broaden local agency participation, then passed SB 99 to Judiciary on a 5-0 vote. SB 758 by Senator Umberg, as amended, would make the sale or distribution of products with unnaturally concentrated 7-hydroxymitragynine (7-OH) a misdemeanor and would restrict nitrous oxide sales by tobacco retailers while preserving legitimate culinary and medicinal uses. Supporters, including local governments, law enforcement, and public safety advocates, described widespread misuse of nitrous oxide and 7-OH, especially among youth, and cited poisonings, injuries, and deaths. Opponents argued the bill would criminalize adults using kratom-related products for pain relief or harm reduction, questioned the scientific evidence, and urged a regulatory or public health approach instead of prohibition. Committee members largely agreed the issue raised public health questions and supported moving the bill forward with amendments; SB 758 passed to Appropriations on a 5-0 vote.

Transcript Highlights:

• One of the barriers I'm crossing mentally is: how did you get your private label?
• Sure, there's several ways that you can get a private label.
• It depends on how it's labeled.
• private label.
• , and providing the best or the majority of shelf space to private label brands.

Committee: Joint Joint Committee on Consumer Protection and Professional Licensure

Summary: The Joint Committee on Consumer Protection and Professional Licensure held a hearing on alcohol licensing, sales, and consumption issues affecting bars, restaurants, package stores, and local communities. The chair outlined hybrid hearing procedures, including three-minute testimony limits and instructions for written testimony. The committee heard a local bill for Milford, H. 4169, authorizing an additional off-premises all-alcohol license for Charlie’s Mini Mart, with the understanding that the existing wine and malt license would be surrendered if the new license is granted. A major topic was the long-running debate over happy hour. The Massachusetts Restaurant Association opposed bills such as S. 217, H. 349, and H. 443, arguing that discounted alcohol would intensify competition, create pressure on restaurants to participate, and potentially raise liquor liability and insurance costs. In contrast, Senator Julian Cyr testified in support of repealing the happy hour ban through a local-option framework, saying the bill includes safeguards such as no discounts after 10 p.m., fixed pricing during promotions, and advance posting requirements, and that it could help downtowns and seasonal businesses without creating a public health risk. The Massachusetts Package Stores Association testified on a broad package of bills, opposing measures to reinstate happy hour, allow supplier control over retail shelf space (H. 350), impose a transfer fee on licenses (H. 351), authorize alcohol coupons or discounts (H. 381 and S. 219), and permit Thanksgiving alcohol sales (H. 428). It supported bills requiring beverage alcohol training for off-premise licensees (H. 344), restricting self-checkout for alcohol (H. 366), changing Section 15 grocery-store license rules (S. 213), and several other regulatory changes. The Distilled Spirits Council supported H. 350 on private label spirits, while acknowledging concerns about disclosure and preferential treatment; package store witnesses defended private labels as lawful products they create with manufacturers, and the council argued the bill should address consumer confusion and unfair competitive advantages. The hearing concluded with Chair Chan announcing committee poll results on other bills, including a number of favorable reports and study orders, and the committee then voted to close the hearing.

Transcript Highlights:

• Line 1295 reflects restoring the funding to local public health cannabis grants.
• Line 1361 is a reduction to cannabis youth grants.
• The labeling for social media.
• I don't know that warning labels are my preference.
• It's a little bit like putting warning labels on a cigarette pack.

Bills: HF2435

Committee: House Health Finance and Policy

Transcript Highlights:

• registration of a pesticide after a hearing if the director determines that the pesticide or its labeling
• registration of a pesticide after a hearing if the director determines that the pesticide or its labeling
• This bill authorizes licensed cannabis 18th.
• It's just about authorizing agricultural cooperatives in the cannabis industry.
• As we know, cannabis is an agricultural product.

Summary: The House Agriculture and Natural Resources Committee heard public testimony on House Bill 2279, which would require the Department of Agriculture to create a program and criteria to evaluate PFAS chemicals in fertilizers and pesticides. The prime sponsor argued PFAS are persistent “forever chemicals” that are entering soil, water, wildlife, and people, and said Washington should begin acting now rather than waiting for federal action. WSDA said the bill is implementable but would require rulemaking, ongoing staff resources, and likely a 12-month extension to complete stakeholder engagement; it also noted the bill should be clarified to address all pesticides, not just new ones. Agricultural and industry witnesses opposed the bill as duplicative of EPA review and warned it could reduce product availability and put Washington farmers at a competitive disadvantage, while environmental advocates supported it as a needed food-safety and environmental measure. No vote was taken on the bill during the hearing. The committee then heard House Bill 2463, which would expand the Washington Commodity Donation Program and create a Farm to Food Pantry Program to help hunger-relief organizations buy Washington-grown food directly from farmers. The sponsor said the bill is part of a broader state response to reduced federal food-security support and is intended to keep families fed by strengthening local food purchasing. Testimony was largely supportive from food banks, food hubs, farmers, AARP, and hunger-relief groups, who said the programs help move surplus produce, dairy, protein, and other products to people in need while supporting local farms and reducing waste. Several witnesses, however, raised concerns about language limiting participation to organizations that “solely” function for food sourcing, saying it could exclude many existing regional organizations and reduce resilience; one tribal representative also requested an amendment to include tribally owned small-scale farms. No action was taken on HB 2463 during the hearing. After the hearings, the committee went into caucus and then held executive session only on House Bill 1941, which authorizes licensed cannabis producers to form agricultural associations for collective processing, handling, and marketing. Supporters said it would help smaller cannabis producers cooperate and prepare for possible federal changes, while opponents argued it was premature given marijuana’s federal status and too broad in scope. The committee approved HB 1941 on a 6-5 vote and reported it out of committee with a do-pass recommendation. House Bill 2238 was deferred to the following day for further review of amendments.

Transcript Highlights:

• How cannabis has helped some medical doctors help patients get off opioids and narcotics.
• Even our Oreos, they sort of play off on that, on different labels.
• I keep hearing nobody's ever died from cannabis.
• There seem to be very few long-term consequences to cannabis use, actually.
• Cannabis is one of the easiest drugs to get. comes across the border every day.

Bills: SB5 , SB11 , SB12 , SB9 , SB42 , SB15 , SB5 , SB11 , SB12 , SCR1

Keywords: hemp regulation, consumable products, cannabinoids, occupational licenses, criminal offenses, SB 11, Texas attorney general, election crimes, election law enforcement, criminal prosecution, Election Code, Government Code Chapter 402, local prosecutors, county attorney, district attorney, grand jury, probable cause reports, state election offenses, voter fraud, election integrity

Transcript Highlights:

• Laws, as you all know, provide no uniform testing, no labeling, and no age restrictions.
• Moving on to adult use cannabis, again this is the molecule.
• Prohibition of cannabis and THC has never really been about science or safety.
• And let me add here, there's a lot of comparison between alcohol and cannabis.
• Recurring cannabis and THC are very, very different.

Bills: SB5 , SB11 , SB12 , SB9 , SB42 , SB15 , SB5 , SB11 , SB12 , SCR1

Transcript Highlights:

• apologize for missing the last Senate criminal justice hearing on this issue because it was also cannabis
• So suddenly the smell of cannabis can turn into an arrest, and then we're having to deal with a dismissal
• So in that case, you know, and like we always say, if you're consuming any cannabis product, you should
• But the fact of the matter is that... ...cannabis consumers have always received this bias because cannabis—if
• Them, the label to the medication didn't tell them.

Committee: Senate Appropriations Committee on Criminal and Civil Justice

Summary: The Appropriations Committee on Criminal and Civil Justice met with a quorum and first approved SPB 7014, which terminates the state court system’s mediation and arbitration trust fund; staff noted the fund has no current balance and that filing fees were already redirected in 2011. The bill was reported favorably as a committee bill without objection. The committee then took up CS/SB 48 on alternative judicial procedures for foreclosure sales. Senator Garcia described it as a response to reported abuses in Miami-Dade County, adding longer sale timeframes, stronger notice requirements, rules for alternative sale methods, online auction authorization, and consumer protections for surplus funds. After adopting a technical amendment, members raised concerns about whether the bill was codifying a process they believed should remain with clerks of court and about the new online auction provisions; Senator Garcia ultimately moved to temporarily postpone the bill. Members also approved CS/SB 322, creating a nonjudicial process for sheriffs to remove unauthorized persons from commercial property, and CS/SB 138, which revises DUI-related language from “intoxicating” to “impairing” and allows judicial circuits to create DUI diversion programs. CS/SB 138 drew opposition from some members and testimony from cannabis advocates and defense lawyers who argued the catch-all language was too broad and could sweep in lawful medications or create testing and expungement issues, but it still passed. The committee further reported favorably SB 130 on wrongful incarceration compensation, extending filing deadlines and removing restrictive bars to compensation, and SB 234, which strengthens penalties for violent resistance against law enforcement officers and clarifies that such resistance can lead to life imprisonment if it results in an officer’s death. Both bills received supportive testimony, though SB 234 also drew concerns from defense lawyers about removing language tied to lawful duty and good faith; the sponsor said the bill preserves defenses while focusing on violent resistance. The meeting then adjourned.

Transcript Highlights:

• It's marketed under candy labels.
• , but if we fully legalized cannabis, the natural cannabis, you wouldn't have this industry.
• And I guess at this stage is there are other non-prescription Maranol and so. of those other cannabis
• And so whether I want to go out and regulate cannabis totally. in a regulated fashion like they do in
• And I've seen how cannabis, under a healthcare provider's direction, can. change lives.

Bills: SCR5 , SCR13 , SB3 , SB6 , SB10 , SB12 , SB13 , SB15 , SB17 , SB18 , SB19 , SB24 , SB35 , SB57 , SB65 , SB112 , SB284 , SB290 , SB388 , SB400 , SB402 , SB412 , SB495 , SB499 , SB502 , SB509 , SB621 , SB706 , SB740 , SB815 , SB842 , SB854 , SB875 , SB893 , SB917 , SB974 , SB1025 , SB1061 , SB1073 , SB1106 , SB1268 , SB1281 , SB1300 , SB1362 , SB1379 , SB1447 , SB1451 , SB1555 , SB1902 , SJR36 , SJR12 , SCR13 , SCR25 , SCR5 , SCR22 , SCR12 , SCR24 , SB495 , SB412 , SB10 , SB18 , SB565 , SB372 , SB842 , SB765 , SB62 , SB19 , SB666 , SB707 , SB888 , SB687 , SB706 , SB847 , SB290 , SB13 , SB1248 , SB740 , SB14 , SB1006 , SB504 , SB917 , SB925 , SB388 , SB1902 , SB1121 , SB995 , SB857 , SB305 , SB296 , SB284 , SB35 , SB6 , SB815 , SB3 , SB1281 , SB1379 , SB1300 , SB1497 , SB1499 , SB1498 , SB1451 , SB1061 , SB15 , SB65 , SB241 , SB304 , SB402 , SB499 , SB621 , SB974 , SB1023 , SB1024 , SB1025 , SB1106 , SB686 , SB112 , SB371 , SB204 , SB400 , SB609 , SB1447 , SB670 , SB502 , SB427 , SB850 , SB854 , SB413 , SB1555 , SB1362 , SB1346 , SB1033 , SB1220 , SB1073 , SB810 , SB987 , SB1539 , SB893 , SB447 , SB875 , SB406 , SB509 , SB985 , SB965 , SB17 , SB1119 , SB1505 , SB12 , SB24 , SB57 , SB1194 , SB1253 , SB1215 , SB1532 , SB1268 , SB1302 , SB856 , SB650 , SB583 , SB673 , SB840 , SJR57 , SCR8 , SB213 , SB681 , SB1172 , SB1252 , SB378 , SB610 , SB918 , SB1343 , SB608 , SB487 , SB955 , SB957 , SB988 , SB990 , SB1019 , SB1021 , SB1120 , SB251 , SB958 , SB535 , SB761 , SB1 , SB541 , SB315 , SB379 , SB1018 , SB1737 , SB266 , SB1415